CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 68 filers reported holding CHEMOCENTRYX INC in Q3 2013. The put-call ratio across all filers is 3.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $8,000 | 0.0% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $8,000 | +14.3% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $7,000 | +40.0% | 1,000 | 0.0% | 0.01% | +66.7% |
| Q3 2014 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | -40.0% |
| Q1 2014 | $7,000 | -50.0% | 1,000 | 0.0% | 0.01% | -50.0% |
| Q2 2013 | $14,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |